Immunization, Hib3 (% of children ages 12-23 months) in Central Europe and the Baltics
Central Europe and the Baltics: Immunization, Hib3 (% of children ages 12-23 months) was 90.3% in 2024. ◆ Volatile
Immunization, Hib3 in Central Europe and the Baltics, 1990–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Central Europe and the Baltics stood at 90.3%.
That represents a change of down 0.4% on the previous year and down 5.1% over ten years.
Over the whole period, immunization, hib3 in Central Europe and the Baltics peaked at 96.8% in 2012 and was at its lowest, 0.0%, in 1990.
That places Central Europe and the Baltics 12th out of 43 groups with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, Hib3 (% of children ages 12-23 months) in Central Europe and the Baltics, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.2% | — |
| 1995 | 1.2% | +434.7% |
| 1996 | 0.8% | -28.8% |
| 1997 | 2.8% | +239.7% |
| 1998 | 2.7% | -2.0% |
| 1999 | 12.9% | +370.5% |
| 2000 | 13.6% | +4.9% |
| 2001 | 16.1% | +18.8% |
| 2002 | 29.2% | +81.5% |
| 2003 | 31.2% | +6.9% |
| 2004 | 32.8% | +4.8% |
| 2005 | 41.7% | +27.2% |
| 2006 | 46.8% | +12.3% |
| 2007 | 67.6% | +44.5% |
| 2008 | 71.7% | +6.0% |
| 2009 | 72.4% | +1.1% |
| 2010 | 78.9% | +8.9% |
| 2011 | 96.2% | +22.0% |
| 2012 | 96.8% | +0.6% |
| 2013 | 96.6% | -0.2% |
| 2014 | 95.1% | -1.5% |
| 2015 | 94.9% | -0.2% |
| 2016 | 95.2% | +0.3% |
| 2017 | 92.8% | -2.5% |
| 2018 | 93.4% | +0.7% |
| 2019 | 94.0% | +0.6% |
| 2020 | 93.2% | -0.8% |
| 2021 | 92.4% | -0.9% |
| 2022 | 92.4% | +0.0% |
| 2023 | 90.7% | -1.8% |
| 2024 | 90.3% | -0.4% |
Biggest year-on-year movements
Years where Immunization, Hib3 (% of children ages 12-23 months) in Central Europe and the Baltics changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1995 | +434.7% | 0.2% | 1.2% |
| 1999 | +370.5% | 2.7% | 12.9% |
| 1997 | +239.7% | 0.8% | 2.8% |
| 2002 | +81.5% | 16.1% | 29.2% |
| 2007 | +44.5% | 46.8% | 67.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 2.1% | 0.0% | 12.9% | 10 |
| 2000s | 42.3% | 13.6% | 72.4% | 10 |
| 2010s | 93.4% | 78.9% | 96.8% | 10 |
| 2020s | 91.8% | 90.3% | 93.2% | 5 |
More health data for Central Europe and the Baltics
- Population ages 20-24, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0278 units per person (2025)
- Population ages 20-24, female, annual growth rate -0.8382 % change on previous year (2025)
- Population ages 00-04, male, annual growth rate -3.6 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.024 units per person (2025)
- Population ages 20-24, male, annual growth rate -0.7647 % change on previous year (2025)
- Population ages 00-04, female, per capita 0.0216 units per person (2025)
- Population ages 00-04, female, annual growth rate -3.74 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Central Europe and the Baltics?
- Immunization, hib3 in Central Europe and the Baltics was 90.3% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Central Europe and the Baltics?
- The highest recorded value was 96.8% in 2012.
- What is the lowest immunization, hib3 recorded in Central Europe and the Baltics?
- The lowest recorded value was 0.0% in 1990.
- How does Central Europe and the Baltics rank for immunization, hib3?
- Central Europe and the Baltics ranks 12th out of 43 groups with data for 2024.
- Is immunization, hib3 rising or falling in Central Europe and the Baltics?
- Over the last ten years it is down 5.1%. The long-run trend across the full record is volatile.
- Where does this Central Europe and the Baltics data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.